Status:
COMPLETED
Position Related Changes in Macular Hole Morphology Before and After Surgery
Lead Sponsor:
Helse Stavanger HF
Collaborating Sponsors:
Helse-Bergen HF
Conditions:
Macular Holes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Macular hole is a full thickness retinal defect in the very centre of the retina that gives the sharpest vision. The condition causes a substantial deterioration of visual acuity, and operative measur...
Eligibility Criteria
Inclusion
- Primary macular hole
- Able to sign informed consent
- Signed informed consent
Exclusion
- Previous vitreoretinal surgery in the study eye
- Secondary macular holes caused by other conditions than vitreomacular traction
- Myopic macular hole, i.e. excessive myopia (more than -6 dioptres)
- Posttraumatic macular hole
- Macular holes secondary to retinal detachment or other retinal diseases
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04676217
Start Date
January 1 2021
End Date
May 31 2023
Last Update
November 21 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Haukeland University Hospital
Bergen, Norway, 5021
2
Stavanger University Hospital, Department of Ophthalmology
Stavanger, Norway, 4016